BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 33870119)

  • 1. Impact of COVID-19 On Breast Cancer Management: A Radiological Prespective from A Tertiary Centre.
    Syed A; Kumari G; Kapoor A; Chaitanya S; Sharda P; Chaudhary M; Deori A; Gupta P; Choudhary N; Rao S; Ravi B
    Eur J Breast Health; 2021 Apr; 17(2):180-187. PubMed ID: 33870119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neoadjuvant breast cancer treatment response; tumor size evaluation through different conventional imaging modalities in the NeoDense study.
    Skarping I; Förnvik D; Heide-Jørgensen U; Rydén L; Zackrisson S; Borgquist S
    Acta Oncol; 2020 Dec; 59(12):1528-1537. PubMed ID: 33063567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of p-glycoprotein expression in predicting response to neoadjuvant chemotherapy in breast cancer--a prospective clinical study.
    Chintamani ; Singh JP; Mittal MK; Saxena S; Bansal A; Bhatia A; Kulshreshtha P
    World J Surg Oncol; 2005 Sep; 3():61. PubMed ID: 16164742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Impact of the COVID-19 Pandemic on Breast Cancer Patients.
    İlgün AS; Özmen V
    Eur J Breast Health; 2022 Jan; 18(1):85-90. PubMed ID: 35059596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The actual scenario of neoadjuvant chemotherapy of breast cancer in developing country: a report of 80 cases of breast cancer from a tertiary cancer center in India.
    Das U; Lakshmaiah KC; Govind Babu K; Suresh TM; Lokanatha D; Jacob L; Babu S
    J Cancer Res Clin Oncol; 2014 Oct; 140(10):1777-82. PubMed ID: 24894013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of the Axilla and the Breast After Neoadjuvant Chemotherapy in Patients with Breast Cancer: A Systematic Review.
    Citgez B; Yigit B; Yetkin SG
    Sisli Etfal Hastan Tip Bul; 2021; 55(2):156-161. PubMed ID: 34349589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of 2D/3D Ultrasound to Assess the Response to Neoadjuvant Chemotherapy in Locally Advanced Cervical Cancer.
    Perniola G; Tomao F; Graziano M; Palaia I; Fischetti M; Lecce F; Casorelli A; Di Donato V; Giancotti A; Battaglia FA; Muzii L; Benedetti Panici P
    Oncology; 2020; 98(11):807-813. PubMed ID: 32892198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of neoadjuvant chemotherapy on surgical complications in breast cancer: A systematic review and meta-analysis.
    Lorentzen T; Heidemann LN; Möller S; Bille C
    Eur J Surg Oncol; 2022 Jan; 48(1):44-52. PubMed ID: 34548216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of time to breast cancer surgery after neoadjuvant chemotherapy on survival outcomes.
    Al-Masri M; Aljalabneh B; Al-Najjar H; Al-Shamaileh T
    Breast Cancer Res Treat; 2021 Feb; 186(1):7-13. PubMed ID: 33475879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RESPONDER - diagnosis of pathological complete response by vacuum-assisted biopsy after neoadjuvant chemotherapy in breast Cancer - a multicenter, confirmative, one-armed, intra-individually-controlled, open, diagnostic trial.
    Heil J; Sinn P; Richter H; Pfob A; Schaefgen B; Hennigs A; Riedel F; Thomas B; Thill M; Hahn M; Blohmer JU; Kuemmel S; Karsten MM; Reinisch M; Hackmann J; Reimer T; Rauch G; Golatta M
    BMC Cancer; 2018 Aug; 18(1):851. PubMed ID: 30144818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of COVID-19 Pandemic on Surgical Breast Cancer Patients Undergoing Neoadjuvant Therapy: A Multicentric Study.
    Vanni G; Pellicciaro M; Combi F; Papi S; Materazzo M; Segattini S; Rizza S; Chiocchi M; Perretta T; Meucci R; Portarena I; Pistolese CA; Ielpo B; Campanelli M; Lisi G; Chiaravalloti A; Tazzioli G; Buonomo OC
    Anticancer Res; 2021 Sep; 41(9):4535-4542. PubMed ID: 34475080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early progression of breast cancer during neoadjuvant chemotherapy may predict poorer prognoses.
    Myller S; Ipatti P; Jääskeläinen A; Haapasaari KM; Jukkola A; Karihtala P
    Acta Oncol; 2020 Sep; 59(9):1036-1042. PubMed ID: 32394761
    [No Abstract]   [Full Text] [Related]  

  • 13. Impact of COVID-19 on Breast Cancer Management in a Multiethnic Middle-Income Asian Country Setting.
    Hui NJ; Hoong SM; Min TJ; Sze TM; Danaee M; Latiff NSA; Murali AA; Lai LL
    Eur J Breast Health; 2023 Apr; 19(2):177-183. PubMed ID: 37025571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting pathological axillary lymph node status with ultrasound following neoadjuvant therapy for breast cancer.
    Skarping I; Förnvik D; Zackrisson S; Borgquist S; Rydén L
    Breast Cancer Res Treat; 2021 Aug; 189(1):131-144. PubMed ID: 34120224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Response to neoadjuvant treatment of invasive ductal breast carcinomas including outcome evaluation: MRI analysis by an automatic CAD system in comparison to visual evaluation.
    Böttcher J; Renz DM; Zahm DM; Pfeil A; Fallenberg EM; Streitparth F; Maurer MH; Hamm B; Engelken FJ
    Acta Oncol; 2014 Jun; 53(6):759-68. PubMed ID: 24299492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rate of Breast-Conserving Surgery vs Mastectomy in Breast Cancer: a Tertiary Care Centre Experience from South India.
    Hassan Ali S; S P S; N AK
    Indian J Surg Oncol; 2019 Mar; 10(1):72-76. PubMed ID: 30948876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes and disruptions in diagnosis, treatment and follow-up of breast cancer during two periods of the COVID-19 pandemic in Turkey.
    Güler SA; Özkan Güler Ö; Şimşek T; Cantürk NZ
    Turk J Surg; 2021 Sep; 37(3):222-231. PubMed ID: 35112056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical Outcomes of Primary Versus Post-Neoadjuvant Chemotherapy Breast Conservation Surgery: A Comparative Study from a Developing Country.
    Agarwal G; Sonthineni C; Mayilvaganan S; Mishra A; Lal P; Agrawal V
    World J Surg; 2018 May; 42(5):1364-1374. PubMed ID: 29349483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study on predictive role of AR and EGFR family genes with response to neoadjuvant chemotherapy in locally advanced breast cancer in Indian women.
    Singh LC; Chakraborty A; Mishra AK; Devi TR; Sugandhi N; Chintamani C; Bhatnagar D; Kapur S; Saxena S
    Med Oncol; 2012 Jun; 29(2):539-46. PubMed ID: 21528410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A study on clinico-pathological assessment of response to neoadjuvant chemotherapy in breast carcinoma.
    Mohapatra M; Sarma YS
    J Cancer Res Ther; 2020; 16(6):1419-1425. PubMed ID: 33342807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.